邯郸马丽亚妇科医院黑不黑(邯郸月经时间长的原因) (今日更新中)

SAN DIEGO (KGTV) - Jo Anne Bilodeau finds peace inside the grounds of her serene San Carlos apartment complex, filled with greenery, benches, a clubhouse and a pool.Even her rent is less than ,100 a month. "It kind of feels like a sanctuary," she says. But Bilodeau's days in San Diego could be numbered, all because of a specialty shot she takes every 12 weeks. RELATED: Making It in San Diego: Prescription medication costs impacting San Diego families"It's just scary," Bilodeau says. "It makes you feel like you're in limbo all the time because you don't know the exact cost of the drug until you get a bill."Bilodeau suffers from Rheumatoid Arthritis, an autoimmune disease that causes the body to mistakenly attack the joints. She's about to turn 71 and on medical leave from her job, meaning her company health benefits are expiring. That leaves her with just Medicare, and what she believes will be a ,300 co-insurance payment on the drug."I have my days," she says. "I have meltdowns where I just cry because I'm worried and scared."Bilodeau isn't the only one with that anxiety.A new study by AARP says the price for specialty prescription drugs, ones that are generally infused or injected, rose 7 percent in 2017. That's more than three times the rate of inflation. The average annual cost for these drugs is nearly ,000. RELATED: Making It in San Diego: How to save money on your prescriptions"The prices for those medications has risen dramatically," said Leslie Ritter, a senior director at the National Multiple Sclerosis society, a condition that also requires specialty drugs.Ritter says patients on the medications have skipped doses and racked up credit card debt. "Medications only work if you're adhering to them, and you're taking them as prescribed," she says. Federal and State governments are now moving legislation to help lower prices and increase transparency. In the meantime, Leigh Purvis, of the AARP Public Policy Institute, said the best thing to do is for patients to talk to their health care providers to see if there is a less expensive generic alternative to treat the same condition.Drug manufacturers themselves also offer patient assistance programs to those who are eligible. However, they are only available to privately and commercially insured patients, not those on Medicare. 2338

SAN DIEGO (KGTV) — It's been 25 years since President Bill Clinton approved Operation Gatekeeper, the measure focused on the issue of immigrants crossing the border illegally — specifically the San Diego sector.Two key parts of Operation Gatekeeper were surveillance equipment and enforcement infrastructure, like walls and fences. Twenty-five years later, Border Patrol Agent Theron Francisco tells 10News, "Before Gatekeeper this area was in utter chaos, agents were apprehending 1,000 per shift. We had hundred of thousands of apprehensions a year." It's a measure that Francisco says paved the way for Border Patrol today."It's absolutely night and day from where we were back then," Francisco said.Tuesday, those against Operation Gatekeeper held a rally. Former Border Patrol agent Jenn Budd tells 10News, "That was the whole purpose, to push them out here to make it more difficult and dangerous for them to cross. I didn't want to be a part of it but its something I have to admit I was a part of."Budd tells 10News, it's partly why she left Border Patrol, "I left because I felt the policies we were enacting were killing people and what we were representing to the public wasn't the truth." Meantime, Border Patrol agents say it's only helped increase San Diego safety."The days are gone where illegal aliens are running through people's backyards trying to hide from Border Patrol," Francisco added. Budd says, "We need them to work for us, we need them to protect our borders we need them to keep drug smugglers out, but we don't need children dying in their custody and all sorts of things they're doing right now." 1637

SAN DIEGO (KGTV) — It’s a term we’ve heard a lot during the pandemic: emergency use authorization.From ventilators to diagnostic tests to experimental drugs like remdesivir, the Food and Drug Administration has issued at least 616 emergency use authorizations, or EUAs, since the pandemic began.“That’s such a powerful term: emergency use authorization,” said President Donald Trump on Aug. 23 when announcing an EUA for convalescent plasma.Top officials at the FDA are now floating the idea of using an EUA to speed up distribution of a vaccine against COVID-19, writing that it “may be appropriate” under certain circumstances. Critics contend it would be a dangerous move.The mechanism was put into law back in 2004, and EUAs have been used in several health emergencies since, including the 2009 H1N1 pandemic.An EUA allows the FDA to temporarily authorize a drug or device for use during an emergency under certain conditions. There must be no formally approved alternatives to the product, and the available evidence must suggest the potential benefits outweigh the potential risks.“Because in some emergencies, we just cannot wait for all the evidence needed for full FDA approval,” the agency says in a video explaining the rationale for an EUA.While EUAs are relatively common for diagnostic tests and experimental drugs, there has only been one EUA issued for a vaccine. In 2005, the FDA authorized a vaccine intended to protect U.S. soldiers from an anthrax chemical attack. It was the first time the FDA ever used the EUA process. In that case, the product, Anthrax Vaccine Absorbed, had been formally licensed in 1970 as safe and effective against anthrax on the skin, but was not formally approved to counteract inhaled anthrax.In a letter to pharmaceutical companies, the FDA said it “may be appropriate” to issue an EUA for a COVID-19 vaccine “once studies have demonstrated the safety and effectiveness” of the product, but before other steps in the traditional submission process, like detailed information on how the vaccine was made and tested.“It is extremely rigorous,” Dr. Christian Ramers of Family Health Centers of San Diego said of the typical FDA approval process. “People have to submit thousands of pages of documents. They have to open their books, essentially, and show all of the detail on how these things have been tested.”An EUA could allow for the release of a vaccine before the election, something President Trump has suggested but other members of his administration have said is unlikely.The prospect of an EUA for a vaccine alarms consumer advocates like Dr. Sidney Wolfe of Public Citizen, who sent a letter to the agency urging it to avoid the expedited process.“The amount of information on how effective it is, the amount of information on how safe it is is less than would be required for full approval,” Wolfe said. “And full approval could arguably come in three or four months.”Wolfe thinks an EUA could backfire.“The loss of confidence by people will contribute to a much decreased willingness to be vaccinated,” he said, citing a survey during the 2009 H1N1 pandemic that showed people were reluctant to volunteer for inoculation if the vaccine only had emergency authorization.Critics say there’s already shaky public confidence after reports of political pressure from the president in the EUAs for convalescent plasma and for hydroxychloroquine.In the latter case, the FDA revoked the EUA for the anti-malaria drug June 15 after more studies showed it wasn’t effective and could have serious side effects.Dr. Ramers at Family Health Centers of San Diego says there is a big ethical difference between authorizing an experimental drug with limited data and authorizing a vaccine.Fundamentally, doctors give drugs to patients who are already sick, and they're more willing to try something untested in a last-ditch effort. “In somebody who has been through two or three or four rounds of [chemotherapy] and nothing has worked, the risks and benefits are tilted in a different way,” he said.“But a vaccine is a really special situation because we’re giving it to healthy people. We’re giving it to the general population before they become ill. So historically, the safety threshold for a vaccine has been way, way, way higher,” Ramers added. 4302

SAN DIEGO (KGTV) - It's Signing Day for Lincoln High School seniors.In a first-ever ceremony for the school, college-bound seniors were honored for their hard work and accomplishments on campus Tuesday."It is to inspire underclassmen to aspire towards greatness like their senior counterparts," ASB advisor Malykke Bacon said in an email. "This ceremony is to celebrate these seniors and their accomplishments."RELATED: High Tech Middle student award Navy child of the yearPrincipal Jose Sotoramos took the stage and congratulated seniors before several waves of students stepped on stage and signed their letters of acceptance.Students like Jorge de la Cruz and Jhaunee Diggs plan to stay in-state. Cruz is heading to San Francisco State and become a politician one day. Diggs wants to return to San Diego after attending UC Davis to be a future pediatrician."We have many students doing the right thing every day. This ceremony gives them the opportunity to receive some shine," Bacon added. 1026

SAN DIEGO (KGTV) — If Pfizer's coronavirus vaccine is approved this week, UC San Diego Health anticipates receiving its first allocation of the vaccine next week.The vaccine will be considered on Thursday by the Food and Drug Administration. Once it receives the vaccine, UC San Diego Health says its first vaccinations could occur shortly after."Assuming the U.S. Food and Drug Administration issues an Emergency Use Authorization tomorrow or Friday, we would anticipate arrival of the first allocation of the Pfizer vaccine to UC San Diego Health next week, with the first vaccinations occurring shortly thereafter," a statement from the hospital system said. RELATED: What phased vaccine distribution will look like in San Diego CountyThe hospital system says the process of receiving and distributing the vaccine remains fluid and details still need to be finalized.Who will receive the vaccine first will be based on the CDC's Advisory Committee on Immunization Practices, which recommends health care workers receive the vaccination first, along with residents and workers of nursing homes and long-term care facilities.RELATED: What the FDA's review reveals about Pfizer's COVID-19 vaccinePrioritization of who in those first groups receives a vaccination first will also depend on doses available. But those health care workers who face the greatest exposure to COVID-19 patients will be prioritized.This week, an outside group of vaccine experts will advise the FDA and vote on whether to recommend an emergency use authorization for the drug.FDA scientists independently confirmed Pfizer’s claim that its vaccine is 95% effective after two doses and said they found no serious safety concerns, according to documents released Tuesday.Upon approval, California is set to receive 327,000 doses of the vaccine in the first round of allocation. Of those San Diego County is scheduled to receive 28,275 doses. The second round of vaccine allocation is expected within 3-4 weeks. 1991

来源：资阳报